Next webinar coming up:

Recordings of all previous webinars are available here:

Converting Gram-positive-only compounds into broad-spectrum antibiotics
7 November 2019

Natural product antibiotics: from traditional screening to novel discovery approaches
3 October 2019

Models for antimicrobial R&D: Advanced and complex in vivo models for infectious disease research
10 September 2019

Models for antimicrobial R&D: <br>Computational modelling for population PK and PKPD</br> — Models for antimicrobial R&D: Computational modelling for population PK and PKPD
20 August 2019

Enabling academia to fill the discovery gap – Learnings from industry and funders
18 July 2019

Infection models for antimicrobial R&D: Intracellular models
9 July 2019

Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics
26 June 2019

Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research
11 June 2019

Mining Chemical Libraries for New Antibacterials – Session 2
4 June 2019

Mining Chemical Libraries for New Antibacterials
21 May 2019

<br>Antibacterial drugs: Clinical development for non-developers </br> Part 3: Non-traditional approaches — Antibacterial drugs: Clinical development for non-developers Part 3: Non-traditional approaches
28 March 2019

<br>NIAID Resources to Facilitate Discovery & Development </br>of Anti-Infectives — NIAID Resources to Facilitate Discovery & Development of Anti-Infectives
21 February 2019

« Previous
1
2
3
4
Next »

Share

Facebook Twitter Reddit LinkedIn Email

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose the greatest threat to health. We were created to ensure that everyone who needs antibiotics receives effective and affordable treatment, no matter where they live. We aim to develop five new treatments by 2025 to fight drug-resistant infections, focusing on sexually transmitted infections, sepsis in newborns and infections in hospitalized adults and children.

Content

Antimicrobial Viewpoints (36)
Conferences recordings (18)
Experts (129)
External webinars (19)
Uncategorized (2)
Webinars (40)

Search site

Search for:

CONNECT

Twitter
LinkedIn
YouTube

GARDP
DNDi

Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy

We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our cookie policy